Literature DB >> 25988937

Modern Palliative Treatments for Metastatic Bone Disease: Awareness of Advantages, Disadvantages, and Guidance.

Andreas F Mavrogenis1, Andrea Angelini, Christos Vottis, Elisa Pala, Teresa Calabrò, Panayiotis J Papagelopoulos, Pietro Ruggieri.   

Abstract

BACKGROUND: Metastatic disease is the most common malignancy of the bone. Prostate, breast, lung, kidney, and thyroid cancer account for 80% of skeletal metastases. Bone metastases are associated with significant skeletal morbidity including severe bone pain, pathologic fractures, spinal cord or nerve roots compression, and malignant hypercalcemia. These events compromise greatly the quality of life of the patients. The treatment of cancer patients with bone metastases is mostly aimed at palliation.
OBJECTIVE: This article aims to present these palliative treatments for the patients with bone metastases, summarize the clinical applications, and review the techniques and results.
METHODS: It gives an extensive overview of the possibilities of palliation in patients with metastatic cancer to the bone. RESULTS AND DISCUSSION: Currently, modern treatments are available for the palliative management of patients with metastatic bone disease. These include modern radiation therapy, chemotherapy, embolization, electrochemotherapy, radiofrequency ablation, and high-intensity focused ultrasound. As such it is of interest for all physicians with no experience with these developments to make palliative procedures safer and more reliable.

Entities:  

Mesh:

Year:  2016        PMID: 25988937     DOI: 10.1097/AJP.0000000000000255

Source DB:  PubMed          Journal:  Clin J Pain        ISSN: 0749-8047            Impact factor:   3.442


  16 in total

Review 1.  MRI-guided focused ultrasound surgery in musculoskeletal diseases: the hot topics.

Authors:  Alberto Bazzocchi; Alessandro Napoli; Beatrice Sacconi; Giuseppe Battista; Giuseppe Guglielmi; Carlo Catalano; Ugo Albisinni
Journal:  Br J Radiol       Date:  2015-11-26       Impact factor: 3.039

Review 2.  Musculoskeletal Metastases Management: The Interventional Radiologist's Toolbox.

Authors:  Charles Mastier; Ana Gjorgjievska; Arnaud Thivolet; Amine Bouhamama; Marie Cuinet; Franck Pilleul; Lambros Tselikas; Thierry de Baère; Frederic Deschamps
Journal:  Semin Intervent Radiol       Date:  2018-11-05       Impact factor: 1.513

Review 3.  Cytoreduction for colorectal metastases: liver, lung, peritoneum, lymph nodes, bone, brain. When does it palliate, prolong survival, and potentially cure?

Authors:  Camille L Stewart; Susanne Warner; Kaori Ito; Mustafa Raoof; Geena X Wu; Jonathan Kessler; Jae Y Kim; Yuman Fong
Journal:  Curr Probl Surg       Date:  2018-10-04       Impact factor: 1.909

4.  Thyroid cancer-related bone metastases: increasingly good prospects for treatment.

Authors:  Leonidas H Duntas
Journal:  Endocrine       Date:  2018-05-19       Impact factor: 3.633

Review 5.  Metastatic bone disease from breast cancer: a review of minimally invasive techniques for diagnosis and treatment.

Authors:  Dimitrios Filippiadis; Andreas F Mavrogenis; Argyro Mazioti; Konstantinos Palialexis; Panayiotis D Megaloikonomos; Panayiotis J Papagelopoulos; Alexis Kelekis
Journal:  Eur J Orthop Surg Traumatol       Date:  2017-06-08

6.  Can We Estimate Short- and Intermediate-term Survival in Patients Undergoing Surgery for Metastatic Bone Disease?

Authors:  Jonathan A Forsberg; Rikard Wedin; Patrick J Boland; John H Healey
Journal:  Clin Orthop Relat Res       Date:  2016-12-01       Impact factor: 4.176

Review 7.  Minimally Invasive Interventional Procedures for Metastatic Bone Disease: A Comprehensive Review.

Authors:  Nicolas Papalexis; Anna Parmeggiani; Giuliano Peta; Paolo Spinnato; Marco Miceli; Giancarlo Facchini
Journal:  Curr Oncol       Date:  2022-06-07       Impact factor: 3.109

8.  Chemoembolization for Symptomatic Metastatic Epidural Spinal Cord Compression Refractory to Re-radiotherapy.

Authors:  Joichi Heianna; Wataru Makino; Masafumi Toguchi; Takeaki Kusada; Tomotaka Iraha; Kazuki Ishikawa; Shota Takehara; Hitoshi Maemoto; Takuro Ariga; Sadayuki Murayama
Journal:  Cardiovasc Intervent Radiol       Date:  2021-08-02       Impact factor: 2.740

Review 9.  MDA-9/Syntenin (SDCBP): Novel gene and therapeutic target for cancer metastasis.

Authors:  Swadesh K Das; Santanu Maji; Stephen L Wechman; Praveen Bhoopathi; Anjan K Pradhan; Sarmistha Talukdar; Devanand Sarkar; Joseph Landry; Chunqing Guo; Xiang-Yang Wang; Webster K Cavenee; Luni Emdad; Paul B Fisher
Journal:  Pharmacol Res       Date:  2020-02-13       Impact factor: 7.658

Review 10.  The Role of Hedgehog Signaling in Tumor Induced Bone Disease.

Authors:  Shellese A Cannonier; Julie A Sterling
Journal:  Cancers (Basel)       Date:  2015-08-26       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.